Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

Share Price is delayed by 15 minutes
Get Live Data
701.00    11.00 (1.59%)
Bid:
692.00
Ask:
710.00
Spread: 18.00 (2.601%)
Market Cap: £247.03m
BPM Live PriceLast checked at - London Stock Exchange

Intraday B.p Marsh Share Chart

Interim Dividend Declaration

23 Jan 2025 07:00

RNS Number : 3433U
B.P. Marsh & Partners PLC
23 January 2025
 

23 January 2025

 

B.P. Marsh & Partners Plc

("B.P. Marsh", "the Company" or "the Group")

 

Interim Dividend Declaration

 

B.P. Marsh & Partners Plc (AIM: BPM), the specialist venture capital investor in early stage financial services businesses, is declaring an Interim Dividend of 6.78p per share (the "Interim Dividend").

 

On 29 October 2024, the Company announced its intention to distribute a £5.0m dividend for its 31 January 2026 financial year. The Board agreed this dividend will be paid in two instalments: the Interim Dividend of 6.78p per share (£2.5m in aggregate) payable in February 2025, and the balance payable in July 2025 as a Final Dividend, subject to Shareholder Approval at the Company's Annual General Meeting, which is expected to be held in July 2025.

 

The Interim Dividend of 6.78p per share will be payable on 28 February 2025 to all Shareholders on the Register on 31 January 2025. The associated ex-dividend date is 30 January 2025.

 

It remains the Company's intention to pay a dividend of at least £5.0m per annum in each of the financial years ending 31 January 2027 and 2028, subject always to the Board's right to recommend an increased or decreased Final Dividend, for example in the event of significant realisations or capital commitments.

 

The Board will annually revisit the frequency of dividend payments for subsequent years as it reviews the cash requirements of the Group.

 

 

For further information, please visit www.bpmarsh.co.uk or contact: 

 

B.P. Marsh & Partners Plc

Brian Marsh OBE / Alice Foulk

 

+44 (0)20 7233 3112

Nominated Adviser & Joint Corporate Broker:

Panmure Liberum Limited

Atholl Tweedie / Amrit Mahbubani / Ailsa MacMaster

 

+44 (0)20 7886 2500

Joint Corporate Broker:

Singer Capital Markets Advisory LLP

Charles Leigh Pemberton / James Moat / Asha Chotai

 

+44 (0)20 7496 3000

Financial PR & Investor Relations:

Tavistock

Simon Hudson / Katie Hopkins / Kuba Stawiski

 

bpmarsh@tavistock.co.uk 

+44 (0)20 7920 3150

 

Notes to Editors:

 

B.P. Marsh's current portfolio contains seventeen companies. More detailed descriptions of the portfolio can be found at www.bpmarsh.co.uk.

 

Since formation over 30 years ago, the Company has assembled a management team with considerable experience both in the financial services sector and in managing private equity investments. Many of the directors have worked with each other in previous roles, and all have worked with each other for over ten years.

 

- Ends -

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVPPUMPGUPAGQP
Date   Source Headline
28th Oct 20107:00 amRNSHalf Yearly Report
24th Sep 20107:00 amRNSNotice of Interim Results
22nd Jul 20102:23 pmRNSCompletion of U.S. Risk (UK) Limited Investment
21st Jul 201012:28 pmRNSResult of AGM
22nd Jun 20109:35 amRNSReplacement - Notice of Annual General Meeting
22nd Jun 20107:00 amRNSNotice of Annual General Meeting
10th Jun 201011:05 amRNSReplacement - Investment in U.S. Risk (UK) Limited
10th Jun 20107:00 amRNSInvestment in U.S. Risk (UK) Limited
9th Jun 20103:22 pmRNSDirectors' Loan
2nd Jun 20107:00 amRNSFinal Results
7th May 20107:00 amRNSNotice of Final Results
21st Jan 20107:00 amRNSDisposal
21st Jan 20107:00 amRNSAcquisition
11th Jan 201012:25 pmRNSDirector's Dealing
14th Dec 200910:16 amRNSDirector's Dealing
27th Oct 20097:00 amRNSInterim Results
26th Oct 20093:26 pmRNSHolding(s) in Company
30th Sep 20097:00 amRNSNotice of Interim Results
23rd Jul 200910:41 amRNSAnnual Report and Accounts
21st Jul 20097:00 amRNSResult of AGM
18th Jun 20094:07 pmRNSNotice of AGM
9th Jun 20099:28 amRNSInvestee Company, Hyperion, Announces Acquisition
3rd Jun 20097:00 amRNSLoans to Investee Company
3rd Jun 20097:00 amRNSFinal Results
18th May 20099:52 amRNSChange of Adviser
6th May 200910:58 amRNSNotice of Results
6th Apr 20093:40 pmRNSHolding(s) in Company
26th Mar 200910:11 amRNSHolding of Shares by a Director
2nd Feb 20097:00 amRNSDirectorate Change
9th Dec 20084:23 pmRNSDirector/PDMR Shareholding
4th Dec 20083:26 pmRNSDirectorate Change
3rd Dec 20084:53 pmRNSDirector/PDMR Shareholding
1st Dec 20083:05 pmRNSChange of Registered Office
18th Nov 20083:06 pmRNSDirector/PDMR Shareholding
12th Nov 200812:42 pmRNSDirector/PDMR Shareholding
28th Oct 20087:00 amRNSInterim Results
6th Oct 20082:16 pmRNSNotice of Interim Results
1st Oct 20087:00 amRNSAppointment of Nominated Adviser
24th Jul 20082:24 pmRNSResult of AGM
25th Jun 20087:00 amRNSNotice of AGM
5th Jun 20087:00 amRNSFinal Results
7th May 20082:33 pmRNSNotice of Results
2nd Apr 20089:05 amRNSHyperion partners with 3i
20th Mar 20087:00 amRNSInvestment in Trillium
11th Mar 20087:01 amRNSInvestment in Business Broker
25th Feb 20084:17 pmRNSDirectorate Change
14th Feb 20081:26 pmRNSFurther re: Disposal
12th Feb 20087:01 amRNSDisposal
4th Feb 20082:46 pmRNSIncreased Investment in Summa
27th Nov 20077:01 amRNSBoard Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.